Skip to main content
    I

    iRhythm Technologies Inc (IRTC)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $109.35
    +3.30 (+3.11%)

    Market Cap: $3.55B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(22/39)
    Avg Surprise
    +193.13%
    Streak
    5 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.05
    Range$-0.08 - $0.14
    10 analysts
    EPS Revisions
    2
    0
    7d
    1
    7
    30d
    EPS Estimate DriftChange to current
    90d ago$0.09-47.1%
    60d ago$0.08-42.6%
    30d ago$0.04+12.4%
    7d ago$0.04+12.4%
    Current$0.05
    Revenue Consensus
    $222M
    Range$222M - $223M
    14 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.17
    Range$0.85 - $1.37
    10 analysts
    Revenue Consensus
    $255M
    Range$249M - $277M
    15 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.17---
    Sep 26EST
    		-$0.05---
    Jun 26
    Reported Aug 6
    		$0.58$-0.01+5900.00%Beat+281.2%
    Mar 26
    Reported Apr 30
    		$-0.35$-0.64+45.31%Beat+63.2%
    Dec 25
    Reported Feb 19
    		$0.17$0.01+1600.00%Beat+1600.0%
    Sep 25
    Reported Oct 30
    		$-0.06N/A+78.57%Beat+95.2%
    Jun 25
    Reported Jul 31
    		$-0.32$-0.47+31.91%Beat+47.5%
    Mar 25
    Reported May 1
    		$-0.95$-0.94-1.06%Miss+22.8%
    Dec 24
    Reported Feb 20
    		$0.01N/A+103.57%Beat+100.8%
    Sep 24
    Reported Oct 30
    		$-1.26$-0.57-121.05%Miss-59.5%
    Jun 24
    Reported Aug 1
    		$-0.61$-0.88+30.68%Beat-41.9%
    Mar 24
    Reported May 2
    		$-1.23$-0.99-24.24%Miss-11.8%
    Dec 23
    Reported Feb 22
    		$-1.26$-0.60-110.00%Miss-88.1%
    Sep 23
    Reported Nov 2
    		$-0.79$-0.58-36.21%Miss-25.4%
    Jun 23
    Reported Aug 3
    		$-0.43$-0.75+42.67%Beat+45.6%
    Mar 23
    Reported May 4
    		$-1.10$-0.86-27.91%Miss-37.5%
    Dec 22
    Reported Feb 23
    		$-0.67$-0.62-8.06%Miss+39.1%
    Sep 22
    Reported Nov 1
    		$-0.63$-0.81+22.22%Beat+22.2%
    Jun 22
    Reported Aug 4
    		$-0.79$-0.90+12.22%Beat-33.9%
    Mar 22
    Reported May 5
    		$-0.80$-1.06+24.53%Beat+15.8%
    Dec 21
    Reported Feb 23
    		$-1.10$-1.17+5.98%Beat-233.3%
    Sep 21
    Reported Nov 4
    		$-0.81$-1.07+24.30%Beat-376.5%
    Jun 21
    Reported Aug 5
    		$-0.59$-0.94+37.23%Beat+21.3%
    Mar 21
    Reported May 6
    		$-0.95$-0.85-11.76%Miss-179.4%
    Dec 20
    Reported Feb 25
    		$-0.33$-0.31-6.45%Miss+49.2%
    Sep 20
    Reported Nov 5
    		$-0.17N/A+67.31%Beat+77.0%
    Jun 20
    Reported Aug 6
    		$-0.75$-0.75+0.00%Beat-63.0%
    Mar 20
    Reported May 7
    		$-0.34$-0.59+42.37%Beat-3.0%
    Dec 19
    Reported Feb 27
    		$-0.65$-0.50-30.00%Miss-35.4%
    Sep 19
    Reported Nov 5
    		$-0.74$-0.39-89.74%Miss-72.1%
    Jun 19
    Reported Jul 31
    		$-0.46$-0.44-4.55%Miss+9.8%
    Mar 19
    Reported May 7
    		$-0.33$-0.48+31.25%Beat+29.8%
    Dec 18
    Reported Feb 12
    		$-0.48$-0.45-6.67%Miss+0.0%
    Sep 18
    Reported Oct 30
    		$-0.43$-0.45+4.44%Beat-48.3%
    Jun 18
    Reported Aug 1
    		$-0.51$-0.39-30.77%Miss-75.9%
    Mar 18
    Reported May 2
    		$-0.47$-0.36-30.56%Miss-95.8%
    Dec 17
    Reported Feb 14
    		$-0.48$-0.35-37.14%Miss-29.7%
    Sep 17
    Reported Nov 1
    		$-0.29$-0.32+9.38%Beat-
    Jun 17
    Reported Aug 2
    		$-0.29$-0.29+0.00%Beat-
    Mar 17
    Reported May 3
    		$-0.24$-0.35+31.43%Beat-
    Dec 16
    Reported Feb 15
    		$-0.37$-0.27-37.04%Miss-

    Key Metrics

    Valuation
    P/E Ratio321.62EV/EBITDA708.85x
    Price/FCF92.28xFCF Yield1.08%
    Profitability
    Profit Margin-1.69%Operating Margin7.94%
    ROE-9.63%ROIC-2.48%
    Financial Health
    Debt/Equity3.50xInterest Coverage-1.57x
    Current Ratio3.85xQuick Ratio3.74x
    Trading Statistics
    Beta1.46Avg Volume496.46K
    52-Week High$212.0052-Week Low$100.70

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$107.07
    SMA 20$109.27
    SMA 50$116.14
    SMA 200$125.56
    EMA 10$107.82
    EMA 20$109.54
    EMA 50$113.25
    EMA 200$124.26

    MACD

    Line: -2.43Signal: -2.64Hist: 0.20

    ADX

    ADX: 17.6+DI: 18.3-DI: 21.4

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down80.0
    PSAR$100.99

    Bollinger Bands

    Upper Band$115.17
    Lower Band$103.38
    %B Position1079%(Upper)
    Band Width0.51

    RSI (14-Day)

    Neutral
    47.2

    Momentum Oscillators

    Stoch %K49.5
    Stoch %D44.0
    Williams %R-38.8
    ROC (10d)-1.5%
    Momentum-1.70
    CCI (20d)-24.2
    MFI (14d)47.5

    Volatility Measures

    ATR (14d)$4.01(3.7%)
    StdDev (20d)2.95
    Hist Vol28.7%(Moderate)

    Volume Flow

    VWAP$108.34
    OBV-3.3M
    AD Line-5.3M
    CMF (20d)-0.004

    Volume Metrics

    Avg Vol (20d)503.8K
    Vol Ratio0.7x
    VWMA (20d)$109.23

    Pivot Points

    R3$110.26
    R2$108.80
    R1$107.43
    Pivot Point$105.97
    S1$104.60
    S2$103.14
    S3$101.77

    Advanced Oscillators

    TSI-18.74
    Ultimate Osc59.4
    KST-77.99

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$224.17M$199.39M$208.89M$192.88M$186.69M$158.68M$164.32M$147.54M$148.05M$131.93M$132.51M$124.60M
    Cost of Revenue$60.97M$58.04M$60.84M$55.76M$53.83M$49.46M$49.26M$46.06M$44.58M$44.41M$45.09M$42.13M
    Gross Profit$163.21M$141.35M$148.06M$137.12M$132.86M$109.22M$115.07M$101.48M$103.47M$87.52M$87.43M$82.47M
    Operating Expenses$165.75M$157.54M$145.77M$145.55M$151.56M$141.77M$119.15M$151.78M$126.45M$125.65M$126.61M$110.08M
    R&D$20.14M$21.65M$21.79M$21.34M$22.71M$21.82M$19.38M$47.76M$19.69M$16.99M$15.42M$16.31M
    SG&A$131.66M$135.88M$122.00M$124.22M$126.38M$119.96M$99.77M$103.38M$106.76M$108.66M$100.11M$93.77M
    Operating Income$-2,542,000$-16,185,000$2.29M$-8,429,000$-18,708,000$-32,556,000$-4,083,000$-50,303,000$-22,981,000$-38,138,000$-39,182,000$-27,603,000
    Interest Income$4.78M$4.88M$5.34M$5.94M$5.32M$4.92M$5.74M$6.46M$6.68M$3.06M$0$1.72M
    Interest Expense$3.29M$3.29M$3.32M$3.28M$3.28M$3.27M$3.32M$3.33M$3.31M$10.45M$941,000$927,000
    Income Before Tax$-381,000$-13,433,000$6.03M$-5,188,000$-14,401,000$-30,035,000$-1,182,000$-45,994,000$-19,913,000$-45,635,000$-38,444,000$-26,921,000
    Income Tax Expense$0$500,000$447,000$24,000$-183,000$665,000$151,000$188,000$194,000$32,000$255,000$195,000
    Net Income$-381,000$-13,933,000$5.58M$-5,212,000$-14,218,000$-30,700,000$-1,333,000$-46,182,000$-20,107,000$-45,667,000$-38,699,000$-27,116,000
    EBITDA$4.89M$-8,398,000$10.53M$-1,376,000$-9,800,000$-24,903,000$3.51M$-41,967,000$-16,375,000$-32,198,000$-37,082,000$-23,562,000
    EBIT$-1,863,000$-15,022,000$4.01M$-7,851,000$-16,444,000$-31,681,000$-3,602,000$-49,121,000$-23,286,000$-38,243,000$-42,139,000$-27,711,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IRTC

    News

    Piper Sandler initiates iRhythm stock with overweight rating

    Piper Sandler has initiated coverage on iRhythm Technologies (NASDAQ:IRTC) with an Overweight rating and a $160 price target...

    Investing.com•10/16/26•Bullish

    Needham lifts target for iRhythm Technologies stock to USD 194.00

    Needham has increased its price target for iRhythm Technologies (IRTC) stock to $194.00 from $192.00, citing the company's strong second-quarter revenue of $224.17 million. Despite the stock trading at EUR 95.25...

    ad-hoc-news.de•10/15/26•Bullish

    News - iRhythm said June data breach exposes data of over 360,000 people

    Medical device manufacturer iRhythm disclosed a data security incident from June 2026, affecting over 360,000 individuals. A threat actor exfiltrated sensitive personal information, including names, contact details...

    teiss•10/14/26•Bearish

    (IRTC) as a Liquidity Pulse for Institutional Tactics

    This article provides an AI-driven analysis of Irhythm Technologies Inc. (NASDAQ: IRTC), highlighting weak sentiment across all horizons and suggesting a short bias. It outlines three institutional trading strategies...

    Stock Traders Daily•10/12/26•Bearish

    iRhythm Data Breach Impacts at Least 360,000 People

    Medical equipment provider iRhythm has reported a data breach affecting over 360,000 individuals, where hackers exfiltrated personal and account information from third-party hosted business applications. The company was...

    SecurityWeek•10/12/26•Bearish

    IRTC Valuation and Fair Value

    P/E
    321.6x
    Forward P/E
    90.9x
    EV/EBITDA
    708.9x
    P/FCF
    92.3x
    PEG
    0.0x
    P/B
    19.3x
    See GNG's fair value

    IRTC Profitability: Margins, ROIC and FCF

    Gross margin
    71.5%
    Operating margin
    7.9%
    Net margin
    -1.7%
    ROIC
    -2.5%
    ROE
    -9.6%
    FCF margin
    4.7%
    FCF yield
    1.1%

    IRTC Competitors

    CompanyTicker
    Organon & CoOGN
    Veracyte IncVCYT
    National HealthCare CorporationNHC
    Legend Biotech CorpLEGN
    Telix Pharmaceuticals LimitedTLX
    Pulse Biosciences IncPLSE
    Envista Holdings CorpNVST
    Cidara Therapeutics IncCDTX

    Sector: Healthcare

    IRTC Analyst Ratings

    Consensus
    Buy
    Analysts
    15
    Strong Buy
    2
    Buy
    13
    Hold
    0
    Sell
    0
    Strong Sell
    0

    IRTC Bull Case vs Bear Case

    Bull case

    • IRTC beat EPS estimates in 75.0% of its last 8 reported quarters.
    • IRTC grew quarterly revenue 20.1% year over year.
    • 100.0% of IRTC's analyst ratings are Buy or Strong Buy.

    Bear case

    • IRTC trades at 321.6x trailing earnings.
    • IRTC has a -1.7% net profit margin.
    • IRTC has a debt-to-equity ratio of 3.5x.

    IRTC Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    954.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.05
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 7 down

    Frequently Asked Questions About IRTC

    Does IRTC pay dividends?

    iRhythm Technologies Inc (IRTC) does not currently pay a regular dividend.

    What is IRTC's P/E ratio?

    iRhythm Technologies Inc has a price-to-earnings (P/E) ratio of 321.62.

    What is IRTC's market cap?

    iRhythm Technologies Inc (IRTC) has a market capitalization of $3.55B with a current stock price of $109.35.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In